№ files_lp_4_process_3_126837
File format: docx
Character count: 3481
File size: 34 KB
The document is a review article discussing the interaction between cancer stem cells and the tumor microenvironment and its implications for cancer treatment strategies.
Year:
2023
Region / city:
Zabol, Iran
Theme:
Cancer research, Oncology
Document Type:
Review Article
Organization:
Asian Oncology Research Journal
Author:
Ferydoon Khamooshi
Target Audience:
Scientific community
Period of validity:
Not specified
Approval Date:
Not specified
Date of changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2024
Journal:
Gut
Volume:
73
Pages:
1543–1553
DOI:
10.1136/gutjnl-2024-332033
Authors:
Yang Y; Xu L; Atkins C; et al.
Topic:
Liver regeneration; ischaemia reperfusion injury; immunology; transplantation
Study Type:
Experimental research article
Model System:
Mouse models of liver injury
Key Molecules:
IL-4; IL-13; IL-4Rα; HB-EGF; EGFR
Injury Models:
Ischaemia reperfusion injury; paracetamol-induced injury; carbon tetrachloride-induced injury
Note:
Year
Year:
2026
Field:
Cancer research, spatial transcriptomics
Document type:
Supplementary data / Methods
Authors:
Sammy Ferri-Borgogno, Ying Zhu, Jianting Sheng, Jared K. Burks, Javier Gomez, Kwong Kwok Wong, Stephen T.C. Wong, Samuel C. Mok
Institution:
Unspecified (data from GEO database and previous publications)
Sample:
High-grade serous ovarian cancer patients
Techniques:
scRNA-seq, spatial transcriptomics, UMAP, PCA, GO enrichment analysis
Data source:
GEO database
Cell types analyzed:
Epithelial cells, fibroblasts, endothelial cells, T cells, B cells, myeloid cells, NK cells, dendritic cells, monocytes, macrophages
Analysis period:
Not specified
Methodology details:
Differential expression analysis, cluster annotation, ligand-receptor interaction assessment
Note:
Year
Region / City:
Shanghai, China
Topic:
Tumor Immunology, Hepatocarcinogenesis
Document Type:
Research Supplementary Material
Institution:
Third Affiliated Hospital of Second Military Medical University, National Center for Liver Cancer
Author:
Chen Zong, Yan Meng, Fei Ye, Xue Yang, Rong Li, Jinghua Jiang, Qiudong Zhao, Lu Gao, Zhipeng Han, Lixin Wei
Target Audience:
Researchers in Tumor Immunology, Oncology
Context:
A research document providing detailed methods and experimental procedures on hepatocarcinogenesis and tumor immunology based on single-cell analysis and cell culture experiments.
Year:
2021
Study type:
Clinical research
Document type:
Supplementary materials
Authors:
Not specified
Institution:
Not specified
Target audience:
Researchers in oncology and virology
Tumor types:
Glioma, Meningioma, Pituitary adenoma, Craniopharyngioma, Ependymoma, Schwannoma, Haemangioblastoma, Chordoma, Brain metastases from breast, lung, kidney, colon cancer
Methods:
Immunohistochemistry, Immunofluorescence, Gene expression analysis, KEGG enrichment, GSEA
Patient information:
Age, Sex, Preexisting conditions, Preoperative treatment, SARS-CoV-2 PCR status
Figures included:
S1–S6
Tables included:
S1
Key markers analyzed:
ACE2, TMPRSS2, CD147, NRP1, IFN-γ, PD-1, FOXP3, CD8, CD4, C1q, C3, IgG, IgM, CD68, TTF1, MUC1
Year:
2005
Region / City:
Philadelphia, PA
Topic:
Gastrointestinal Stromal Tumor (GIST), Pathology
Document Type:
Medical Procedural Guide
Organization / Institution:
Elsevier Saunders, Elsevier Churchill Livingstone
Author:
Kumar V, Abbas A, Fausto N, Lester SC
Target Audience:
Medical professionals, Pathologists
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2025
Note:
Region / city
Topic:
Central nervous system tumor diagnostics
Document type:
Scientific article
Author:
Aldape K, Capper D, von Deimling A, Giannini C, Gilbert MR, Hawkins C, Hench J, Jacques TS, Jones D, Louis DN, Mueller S, Orr BA, Nasrallah M, Pfister SM, Sahm F, Snuderl M, Solomon D, Varlet P, Wesseling P
DOI:
10.1093/noajnl/vdae228
PMID:
39902391
PMCID:
PMC11788596
Context:
A scientific article offering guidelines on the use of DNA methylation profiling for diagnosing tumors in the central nervous system.
Protocol for the Examination of Specimens from Patients with Pituitary Neuroendocrine Tumor (PitNET)
Version:
1.0.0.0
Protocol Posting Date:
March 2025
Note:
Procedure
Authors:
Ozgur Mete, MD, Sylvia L. Asa, MD, PhD, Shereen Ezzat, MD, Ian E. McCutcheon, MD, CM, FRCS(C), FACS, William McDonald, MD, Arie Perry, MD
Target Audience:
Medical professionals in oncology and pathology
Date of Protocol Posting:
March 2025
Accreditation Requirement:
Not required for accreditation purposes
Type of Document:
Medical protocol for tumor examination
Version Contributors:
Cancer Committee Authors, Expert Contributors
Date of Creation:
March 2025
Summary of Changes:
v 1.0.0.0 New protocol
Year:
2023
Region / City:
Tianjin, Shijiazhuang, Wuhan
Topic:
Catalytic nanocomposite, chemodynamic therapy, hypoxic tumor
Document Type:
Research paper
Organization / Institution:
Nankai University, Hebei Medical University, Huazhong University of Science and Technology, Sichuan University, HeBei Ex&Invivo Biotechnology Co. Ltd
Author:
Yiran Zhang, Hongzhi Hu, Xiangtian Deng, Qingcheng Song, Xin Xing, Weijian Liu, Yingze Zhang
Target Audience:
Researchers, medical professionals
Period of validity:
N/A
Approval Date:
N/A
Modification Date:
N/A
Note:
Contextual Description
Year:
2026
Region / City:
N/A
Topic:
Cancer research, Immunotherapy
Document Type:
Research article
Organization / Institution:
N/A
Author:
Walid S. Kamoun, Anne-Sophie Dugast, James J. Suchy, Stephanie Grabow, Ross B. Fulton, James F. Sampson, Lia Luus, Michael Santiago, Alexander Koshkaryev, Gang Sun, Vasileios Askoxylakis, Eric Tam, Zhaohua Richard Huang, Daryl C. Drummond, Andrew J. Sawyer
Target Audience:
Researchers, Oncology professionals
Period of Action:
N/A
Approval Date:
N/A
Modification Date:
N/A
Year:
2023
Region / City:
Not specified
Topic:
Tumor Metabolism, Glycolysis, Kinetic Modeling
Document Type:
Research Paper
Institution / Organization:
Not specified
Author:
JHGM van Beek
Target Audience:
Researchers in biochemistry and oncology
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Version:
5.1.0.0
Protocol Posting Date:
September 2025
CAP Laboratory Accreditation Program Protocol Required Use Date:
June 2026
Note:
The changes included in this current protocol version affect accreditation requirements. The new deadline for implementing this protocol version is reflected in the above accreditation date.
Resection:
Includes pneumonectomy, lobectomy, segmentectomy, and wedge resection
Carcinoma:
Includes non-small cell carcinoma, small cell carcinoma, and carcinoid tumor of the lung
Year:
2025
Region / City:
Global
Theme:
Medical Protocol, Oncology
Document Type:
Protocol
Institution:
CAP (College of American Pathologists)
Author:
Frank Schneider, MD, Kirtee Raparia, MD, FCAP
Target Audience:
Medical professionals in pathology and oncology
Period of Validity:
2025-2026
Approval Date:
September 2025
Modification Date:
September 2025
Year:
2026
Region / City:
Rochester, Minnesota, USA; Jinan, Shandong, China; Minneapolis, Minnesota, USA; Corona, California, USA
Subject:
Oncology, Radiobiology, Pharmacology
Document Type:
Supplemental Data / Research Figures and Tables
Institution:
Mayo Clinic; Cheeloo College of Medicine, Shandong University; University of Minnesota; Wayshine Biopharm Inc
Authors:
Zhiyi Xue, Ann C. Mladek, Sneha Rathi, Sonia Jain, Rachael A. Vaubel, Lateef A. Odukoya, Darwin A. Garcia, Lily Liu, Katrina K. Bakken, Brett L. Carlson, Lauren L. Ott, Danielle M. Burgenske, Zeng Hu, Sonja Dragojevic, Paul A. Decker, Matthew L. Kosel, William G. Breen, Shiv K. Gupta, Jeanette E. Eckel-Passow, William F. Elmquist, Wei Zhong, Jann N. Sarkaria
Target Audience:
Researchers in oncology and pharmacology
Experimental Models:
U251, GBM43, GBM120, GBM12, M12eGFP-fLuc2 cell lines; mouse orthotopic xenografts
Treatment Interventions:
WSD0628, radiation therapy, DDR inhibitors
Assays and Measurements:
TR-FRET kinase assay, Western blotting, histological evaluation, survival analysis
Statistical Methods:
Two-sample t-test, median and mean ± SD reporting
Period of Study:
2026
Year:
2021/2022
Region / City:
United States
Theme:
Education, Brain Tumor Support
Document Type:
Scholarship Announcement
Organization / Institution:
Southeastern Brain Tumor Foundation (SBTF)
Author:
Southeastern Brain Tumor Foundation (SBTF)
Target Audience:
Students affected by brain tumors or their family members, enrolled in post-secondary education
Period of Action:
2021/2022 academic year
Approval Date:
N/A
Date of Changes:
N/A
Year:
2023
Region / City:
Ohio, USA
Topic:
Nanotechnology, RNA Nanoparticles, Cancer Targeting
Document Type:
Research Article
Organization / Institution:
The Ohio State University, Wexner Medical Center
Author:
Hongzhi Wang, Chiran Ghimire, Hui Li, Mario Vieweger, Congcong Xu, Peixuan Guo
Target Audience:
Researchers, Scientists, Medical Professionals
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Note:
Context
Year:
2023
Date:
Wednesday, July 19, 2023
Time:
7:00–8:00am
Event Type:
GI Oncology Tumor Board Conference
Session Title:
Patient Case Presentations
Program Director:
Wadlow, Raymond MD
Field:
Gastrointestinal Oncology
Topic:
Colorectal Cancer Treatment and Management
Learning Objectives:
Current chemotherapy, radiation, and surgical guidelines; pre- and post-surgical treatment options; pathological findings including special stains, gene mutations, and differential diagnoses
Target Audience:
Physicians and Allied Healthcare Professionals with an Interest in Oncology
CME Credit:
Maximum 1.0 AMA PRA Category 1 Credit(s)™
Accrediting Body:
Inova Office of Continuing Medical Education
Accreditation Authority:
Medical Society of Virginia
CME Requirement Reference:
Virginia Board of Medicine Continued Competency and Assessment Form
Format:
Live Educational Activity
CME Registration Method:
Text SMS Code CEDKOP to 703-260-9391
Website:
www.oncolens.com
Year:
2023
Region / City:
Not specified
Theme:
Oncology, Colorectal Cancer
Document Type:
Educational Program
Organization / Institution:
Inova Office of Continuing Medical Education
Author:
Wadlow, Raymond MD
Target Audience:
Physicians and Allied Healthcare Professionals with an Interest in Oncology
Period of Validity:
Not specified
Date of Approval:
Not specified
Date of Changes:
Not specified
Credit Designation:
1.0 AMA PRA Category 1 Credit(s)™
Accreditation:
Medical Society of Virginia
Context:
Educational program focused on the management of colorectal cancer, aimed at healthcare professionals.
Year:
2026
Date:
Tuesday, January 27, 2026
Time:
7:00–8:00am
Location:
United States, Washington (virtual meeting)
Meeting ID:
271 618 273 942 6
Phone Conference ID:
796 648 000#
Organizer:
Inova Health System Office of Continuing Medical Education
Accrediting Body:
Southern States CME Collaborative
Accreditation:
ACCME Recognized Accreditor
Credit Designation:
Up to 1.0 AMA PRA Category 1 Credit(s)™
Program Director:
Lauren Turza, MD
Department:
System Cancer Registry Department
Target Audience:
Physicians and Allied Health Professionals with an interest in Oncology
Topic:
Breast Cancer Multi-D Patient Care Discussion
Type of Document:
Continuing Medical Education conference announcement
Credit Claim Information:
Text DEVDOW to 703.260.9391
Year:
2023
Region / City:
Online
Subject:
Oncology, Colorectal Cancer
Document Type:
Educational Program
Institution:
Inova Office of Continuing Medical Education
Author:
Wadlow, Raymond MD
Target Audience:
Physicians and Allied Health Professionals with an Interest in Oncology
Period of Validity:
April 19, 2023
Approval Date:
April 19, 2023
Date of Changes:
None